Adalimumab (Humira) Prefilled Syringe from China
Adalimumab (Humira) is a fully human monoclonal antibody that inhibits tumor necrosis factor-alpha (TNF-alpha), used to treat autoimmune conditions such as rheumatoid arthritis and Crohn's disease. It is presented in pre-filled syringes with measured doses for retail sale, qualifying as an immunological product under tariff item 3002.15.00. This item covers immunological products put up in measured doses or in forms or packings for retail sale.
Duty Rate — China → Canada
0%
Import Tips
• Ensure the product is clearly labelled as a measured dose for retail sale to qualify for this tariff item
• Have the Certificate of Analysis and product monograph ready for CBSA review
• Verify whether a Drug Identification Number (DIN) is required by Health Canada before importation